Recursion Pharmaceuticals (RXRX) is a company that uses science and technology to help discover new medicines. They are expected to announce their financial results for the second quarter of 2024, and experts think that they might do better than what most people expected. The company is working with other big pharmaceutical companies like Roche and Bayer to create new treatments for different types of cancer. They also have some experimental drugs that they are testing for other diseases.

One reason why Recursion Pharmaceuticals might do better than expected is that they have ongoing collaborations with big companies and are expected to share updates on their research soon. Additionally, the company has been investing more in its research and development, which might help them find new treatments faster.

Even though the company's stock has gone down a lot this year, some experts think that it might still do better than other companies in the same industry. Read from source...